Stonepine, Alta Bioequities, 5AM Ventures, 5AM Co-Investors buy shares
By Devika Patel
Knoxville, Tenn., May 13 – Viveve Medical, Inc. said it will raise about $12 million in a private placement of stock. CRT Capital is the agent.
The company will sell common shares at $0.37 apiece. The per-share price represents a 12.12% premium to the May 12 closing share price of $0.33.
Stonepine Capital, LP is the lead investor. Alta Bioequities, LP, 5AM Ventures II, LP and 5AM Co-Investors II, LP are also among the investors.
Settlement is expected May 15.
Proceeds will be used for the commercial launch of the Viveve System.
Based in Sunnyvale, Calif., Viveve is a medical device company.
| Issuer: | Viveve Medical, Inc.
|
| Issue: | Common stock
|
| Amount: | $12 million (approximate)
|
| Price: | $0.37
|
| Warrants: | No
|
| Agents: | CRT Capital
|
| Investors: | Stonepine Capital, LP (lead), Alta Bioequities, LP 5AM Ventures II, LP and 5AM Co-Investors II, LP
|
| Pricing date: | May 13
|
| Settlement date: | May 15
|
| Stock symbol: | OTCBB: VIVMF
|
| Stock price: | $0.33 at close May 12
|
| Market capitalization: | $8.25 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
